Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Cerliponase Alfa

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioMarin Biologic Brineura (Cerliponase Alfa) Receives Suppl Approvals in US
    BioMarin Biologic Brineura (Cerliponase Alfa) Receives Suppl Approvals in US

    24 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052

    FDA
    24 Jul 2024
    Share Share
    Biomarin Pharm`s Biologic Brineura (Cerliponase Alfa) Receives Approval In US
    Biomarin Pharm`s Biologic Brineura (Cerliponase Alfa) Receives Approval In US

    10 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052

    FDA
    10 Jul 2024
    Share Share
    Biomarin Pharm’s Brineura (Cerliponase Alfa)Receives Supplemental Approval In US
    Biomarin Pharm’s Brineura (Cerliponase Alfa)Receives Supplemental Approval In US

    31 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052

    FDA
    31 Mar 2020
    Share Share
    NICE blames BioMarin for Brineura rejection
    NICE blames BioMarin for Brineura rejection

    23 Feb 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/nice-blames-biomarin-for-brineura-rejection-after-price-talks-break-down

    Carly Helfand FIERCE PHARMA
    23 Feb 2019
    Share Share
    Biomarin's Biological Cerliponase Alfa Receives Supplemental Approval in US
    Biomarin's Biological Cerliponase Alfa Receives Supplemental Approval in US

    12 Dec 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052

    FDA
    12 Dec 2018
    Share Share